From: Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study
 | Mucosal melanoma (n = 115), N (%) | Ocular melanoma (n = 14) N (%) | ||||||
---|---|---|---|---|---|---|---|---|
 | Total | Anorectal | Genitourinary | Upper GI | Nasal | Oral | Maxillary sinus |  |
No. | 115 | 39 (30.2) | 21 (16.3) | 6 (4.7%) | 30 (23.3) | 14 (10.9) | 5 (3.9) | 14 (10.9) |
Male (%) | 45 (39.1) | 14 (35.9) | 1 (4.8) | 3 (50.0) | 17 (56.7) | 7 (50.0) | 3 (60.0) | 7 (50.0) |
Age (years) | Â | Â | Â | Â | Â | Â | Â | Â |
   Median | 61 | 62 | 59 | 61 | 63 | 55 | 62 | 64 |
   Range | 26-95 | 31-80 | 26-95 | 43-72 | 39-85 | 33-74 | 35-75 | 28-79 |
ECOG PS | Â | Â | Â | Â | Â | Â | Â | Â |
   0-1 | 113 (98.2) | 38(97.4) | 20(95.2) | 6(100.0) | 30(100.0) | 14(100.0) | 5(100.0) | 13(92.9) |
   ≥ 2 | 2(1.8) | 1(2.6) | 1(4.8) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 1(7.1) |
Presenting symptom | Â | Â | Â | Â | Â | Â | Â | Â |
   Palpable mass | 70(60.9) | 24(61.5) | 16(76.2) | 0(0.0) | 15(50.0) | 13(92.9) | 2(40.0) | 8(57.1) |
   Bleeding | 24(20.9) | 10(25.6) | 4(19.0) | 1(16.7) | 7(23.3) | 0(0.0) | 2(40.0) | 0(0.0) |
   Obstruction | 10(8.7) | 1(2.6) | 0(0.0) | 0(0.0) | 7(23.3) | 1(7.1) | 1(20.0) | 0(0.0) |
   GI symptom | 9(7.8) | 4(10.3) | 0(0.0) | 5(83.3) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) |
   Neurologic symptom | 2(1.7) | 0(0.0) | 1(4.8) | 0(0.0) | 1(3.3) | 0(0.0) | 0(0.0) | 6(42.9) |
Size (n = 101, mm) | Â | Â | Â | Â | Â | Â | Â | Â |
   Median (n) | 20 | 34 (n = 33) | 18.5(n = 14) | 32.5(n = 6) | 30 (n = 22) | 22(n = 10) | 15 (n = 5) | 12 (n = 11) |
   Range | 2-135 | 2-135 | 4-75 | 5-60 | 11-72 | 5-40 | 4-35 | 4-25 |
Lymph node | Â | Â | Â | Â | Â | Â | Â | Â |
   N0 | 78 (67.8) | 24(61.5) | 14(66.7) | 3(50.0) | 26(86.7) | 7(50.0) | 4(80.0) | 14(100.0) |
   N1 | 20(17.4) | 7(17.9) | 5(23.8) | 0(0.0) | 3(10.0) | 5(35.7) | 0(0.0) | 0(0.0) |
   N2 | 5(4.3) | 2(5.1) | 0(0.0) | 1(16.7) | 1(3.3) | 1(7.1) | 0(0.0) | 0(0.0) |
   N3 | 12(10.4) | 6(15.4) | 2(9.5) | 2(33.3) | 0(0.0) | 1(7.1) | 1(20.0) | 0(0.0) |
Metastatic site | Â | Â | Â | Â | Â | Â | Â | Â |
   None | 95(82.6) | 32(82.0) | 18(85.7) | 1(16.7) | 28(93.3) | 12(85.7) | 4(80.0) | 13(92.9) |
   Liver | 10(8.7) | 4(10.3) | 3(14.3) | 2(33.3) | 1(3.3) | 0(0.0) | 0(0.0) | 0(0.0) |
   Lung | 7(6.1) | 1(2.6) | 0(0.0) | 3(50.0) | 0(0.0) | 2(14.3) | 1(20.0) | 1(7.1) |
   Peritoneum | 1(0.8) | 1(2.6) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) |
   Adrenal | 1(0.8) | 0 | 0(0.0) | 0(0.0) | 1(3.3) | 0(0.0) | 0(0.0) | 0(0.0) |
   Bone | 1(0.8) | 1(2.6) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) |